Informations:
Erreur:
ID
24805
Description
Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise; ODM derived from: https://clinicaltrials.gov/show/NCT00478972
Lien
https://clinicaltrials.gov/show/NCT00478972
Mots-clés
Versions (1)
- 18/08/2017 18/08/2017 -
Téléchargé le
18 août 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Obesity NCT00478972
Eligibility Obesity NCT00478972
- StudyEvent: Eligibility
Similar models
Eligibility Obesity NCT00478972
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Non-Insulin-Dependent Diabetes Mellitus Treated Inadequate | Diet therapy | Exercise therapy | Pharmacotherapy Lacking
Item
type 2 diabetes mellitus patients inadequately treated with diet and exercise alone (not drug treated)
boolean
C0011860 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0012159 (UMLS CUI [2])
C0452240 (UMLS CUI [3])
C0013216 (UMLS CUI [4,1])
C0332268 (UMLS CUI [4,2])
C1522326 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0012159 (UMLS CUI [2])
C0452240 (UMLS CUI [3])
C0013216 (UMLS CUI [4,1])
C0332268 (UMLS CUI [4,2])
Glycosylated hemoglobin A
Item
hba1c ≥ 7.0 % and ≤ 10.0 %
boolean
C0019018 (UMLS CUI [1])
Body mass index
Item
body mass index ≥ 25 kg/m²
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Antidiabetics Oral | Insulin | Anti-Obesity Agents | Weight-Loss Agents
Item
within 12 weeks prior to screening visit: use of oral antidiabetic drugs and/or insulin, of anti-obesity drugs or other drugs for weight reduction
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
C0376607 (UMLS CUI [3])
C0376606 (UMLS CUI [4])
C1527415 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
C0376607 (UMLS CUI [3])
C0376606 (UMLS CUI [4])
CORTICOSTEROIDS FOR SYSTEMIC USE Active Long-term | CORTICOSTEROIDS FOR SYSTEMIC USE Intake Prolonged | Lipid-lowering therapy Change
Item
within 4 weeks prior to screening visit: administration of systemic long-acting corticosteroids or prolonged use (more than one week) of other systemic corticosteroids, change in lipid lowering treatment
boolean
C3653708 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0443252 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C0439590 (UMLS CUI [2,3])
C0585943 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C0205177 (UMLS CUI [1,2])
C0443252 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C0439590 (UMLS CUI [2,3])
C0585943 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
secondary obesity
Item
secondary obesity
boolean
C2062945 (UMLS CUI [1])
Hyperlipidemia Primary
Item
primary hyperlipidemia
boolean
C0020473 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,2])
Childbearing Potential Serum pregnancy test positive
Item
positive serum pregnancy test in females of childbearing potential
boolean
C3831118 (UMLS CUI [1,1])
C0430063 (UMLS CUI [1,2])
C0430063 (UMLS CUI [1,2])
Study Subject Participation Status
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])